- Display 45 Products per page
The Global Market for Adjunctive Therapies in Cancer, 2nd Edition
Published: April 1, 2006 | Price: $3,500.00 – $7,000.00
Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and outcomes, but they are also a dynamic area of research and development in a variety of disciplines from drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market. This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to treat and manage symptoms in cancer patients. Market information, including market size and...
The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition
Published: April 1, 2006 | Price: $3,900.00 – $7,800.00
This completely updated edition of Kaloramaās comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including: Point-of-Care Clinical Chemistry Immunoassays Molecular Assays Hematology Coagulation Microbiology and Virology Blood Banking Histology and Cytology Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2010. This new 1,000-page...
The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
Published: March 1, 2006 | Price: $3,000.00 – $6,000.00
This report on the U.S. market for over-the-counter (OTC) pediatric medications presents an in-depth analysis of the performance of non-prescription pediatric drugs and other selected pediatric healthcare products in the marketplace. The analysis captures the performance of the market players, categories, and leading brands in terms of revenue growth and volume growth in several categories of medication, including cough/cold allergy sinus products; first aid products; internal analgesic products, and other pediatric products (chest rubs, nasal products and bedwetting remedies). In...
HIV – A Strategic Analysis of Therapeutic and Testing Markets
Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
The strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in addition to the basic pathology and complications of HIV/AIDS, there are societal and ethical pressures, geopolitical factors, and evolving marketplace disruptions. For the development of a coherent strategy in this therapeutic area, companies must clearly focus on three...
The Impact of the Phase III Pipeline – Future Projections and Market Disruptions
Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is one of the most difficult forecasting projects in market research. In this nearly 500-page analysis, Kalorama Information has compiled all the relevant information about the candidates, their value, and their...
Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)
Published: February 18, 2006 | Price: $2,995.00 – $5,990.00
The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. This report analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities and applications both traditional and...
Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
Published: February 18, 2006 | Price: $2,200.00 – $5,990.00
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can...
The U.S. Market for Private Label OTC Healthcare Products
Published: February 1, 2006 | Price: $3,000.00 – $6,000.00
The private label over-the-counter (OTC) market has been gaining ground rapidly over the past five years. The private label sector has shed its image of being a āme-tooā version of national brands and worked toward offering quality and innovation at an economical price. With benefits for consumers, retailers, and manufacturers, private label healthcare should experience solid growth through the end of the decade. This report on the U.S. market for OTC private label products presents an in-depth analysis of the...
The Worldwide Market for Prescription Dermatological Drugs, 5th Edition
Published: February 1, 2006 | Price: $1,995.00 – $7,800.00
This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fifth time Kalorama Information has comprehensively studied the dermatology markets. As is the case with each new edition, Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of...
The Future of Biotechnology Instrumentation
Published: January 1, 2006 | Price: $2,995.00 – $5,990.00
The field of biotechnology instrumentation has been an expanding one ever since the emergence of the Human Genome Project 20 years ago. Although the filed certainly existed prior to that point in time, it was the Human Genome Project with its major access to key universities, national laboratories, and government funding sources that gave great acceleration to the field. There are several technologies applicable to genomic and proteomic analysis, all of which have become important to the nature of the...
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
Published: January 1, 2006 | Price: $995.00 – $5,990.00
With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launchedārecombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the number of products reaching the market will impose unprecedented demands on the industryās biomanufacturing capacity. Whether or not this will create a biomanufacturing bottleneck is a hotly debated issue in the industry....
The U.S. Market for Over-the-Counter Anti-Infectives
Published: January 1, 2006 | Price: $3,000.00 – $6,000.00
The U.S. Market for OTC anti-infective products surpassed the $2 billion mark last year. Although overall growth is sluggish, the market is a proven revenue source for a number of major brands, and there have been some nice surprises in the performance of some categories, such as first-aid related antiseptic and antibiotic products. This comprehensive report examines all aspects of the U.S. OTC market, including 5-year sales performance by brand and by marketer for the following categories of products: Antifungals...
Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The
Published: January 1, 2006 | Price: $3,500.00 – $7,000.00
The U.S. long-term care industry experienced strong growth from 1999 through 2004 and this growth is expected to continue through the end of the decade. Indeed, the aging of the U.S. population will push unprecedented demand for all forms of long-term care, but ongoing cost containment issues continue to pressure both private and public managed care organizations and make competition in this dynamic environment challenging. This comprehensive study from Kalorama Information details four segments of the long-term care industry, including:...
Outsourcing in Drug Discovery, 2nd Edition
Published: January 1, 2006 | Price: $2,995.00 – $5,990.00
In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous changes that are taking place in the drug discovery outsourcing market, and the forces that are shaping the sector. It presents viewpoints from both customers...
Advanced Drug Delivery – Technologies, Applications, and Markets, 2nd Ed.
Published: November 15, 2005 | Price: $2,500.00 – $7,000.00
This completely updated 2nd edition to Kaloramaās popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, the report considers the options that the current technologies present, the progress that is being made in these fields, and the reception these new products...
Worldwide Market for Pediatric Drugs, 2nd Edition, The
Published: November 1, 2005 | Price: $3,500.00 – $7,000.00
Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment of conditions and diseases affecting pediatrics and the healthy growth of children are vital to providing a solid foundation for healthy adults in the future....
Market for Generic Biologics – Issues, Trends, and Market Potential, 2nd edition, The
Published: November 1, 2005 | Price: $2,500.00 – $5,000.00
Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% per year) to generic competition, ifāand itās a big ifāthe regulatory hurdles for these generics can be overcome. Biogeneric is a new term combining biologic...
Clinical Diagnostics in China – Market Sector Analyses and Participant Directory
Published: November 1, 2005 | Price: $4,995.00 – $9,990.00
There has not been a year in the last decade in which the IVD market in China has failed to grow. With a gross domestic product of over $1.4 trillion, China surpassed Italy last year to become the worldās sixth largest economy, according to the International Monetary Fund. This country of 1.3 billion people is now Americaās sixth largest export market, and Chinaās economy, which has been growing at an average rate of 8% over the last 20 years, grew...
World Market for Respiratory Equipment, The
Published: November 1, 2005 | Price: $3,500.00 – $7,000.00
Respiratory diseases are among the most common ailments across the world. Asthma and chronic obstructive pulmonary disease (COPD) are the major causes of mortality rates among children and elderly. Currently, about 300 million people suffer from asthmaāthe number only expected to rise over next few yearsāand about 14.2 million people suffer from COPD. Given these numbers, itās no wonder that the market for respiratory products is buoyant. This report analyzes the worldwide market for respiratory disposables and reusables, including the...
Worldwide Market for Cancer Diagnostics, The
Published: October 1, 2005 | Price: $3,500.00 – $7,000.00
Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are making continued progress in understanding the disease. Further, cancer drug research is moving from traditional cytotoxic chemotherapies toward higher specificity immunological and biological approaches that...
U.S. Market for Clinical Information Systems – An Analysis of the Growing Use of Information Technology for Hospital-Based Patient Care, The
Published: October 1, 2005 | Price: $895.00 – $5,990.00
Information technology (IT) has the potential to improve the quality, safety and efficiency of clinical care. IT is not new to the hospital setting. Computers and software have been used for many years to improve the paper-based administrative functions of hospital support staff, such as scheduling and billing. But the use of IT in the clinical setting to optimize, streamline and simplify patient records, testing, imaging and operating room procedures has lagged behind its medical administrative applications. The evolution of...
Implant-Based Dental Reconstruction – The Worldwide Implant and Bone Graft Market
Published: September 1, 2005 | Price: $995.00 – $7,000.00
In the industrial world, over 240 million people lack one or more teeth. It is estimated that 40% of the western population is missing one tooth or more. In the United States, approximately 10% is the population is totally edentulous, and every year about two million Americans loose a tooth due to sporting accidents. Although the success of modern dentistry in the United States has vastly decreased the edentulous rate in each succeeding generation, it is estimated there are about...
The U.S. Market For Cardiovascular Devices
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the American population, e.g., stroke and myocardial infarction, these four conditions present the core conditions that lead to more serious cardiovascular accidents and death and present...
Wound Care Markets, 2nd Edition, Vol III – Surgical and Trauma Wounds
Published: September 1, 2005 | Price: $2,995.00 – $5,990.00
Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed daily. Enjoying market success depends on developing a formidable strategy that involves matching internal capabilities with external opportunities. Providers who compete well in this area must offer products that achieve...
The World Market for Neurotherapeutic Drugs
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patientās family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimerās Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
Glycosylated Protein Therapeutics – A Market Briefing
Published: September 1, 2005 | Price: $795.00 – $1,590.00
One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...
Wound Care Markets, 2nd Edition, Vol II – Burns
Published: August 1, 2005 | Price: $2,995.00 – $5,990.00
Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address infection, pain, and a host of long-term complications. Continued advances in biotechnology have driven the burn portion of the wound care industry, estimated at over $1.5 billion globally. New wound...
The Market for Clinical Nutritional Products
Published: August 1, 2005 | Price: $2,500.00 – $5,000.00
This market briefing concentrates on the U.S. market for medical nutritional supportāin particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and techniques have evolved from steady improvements, including the use of antibiotic materials, biosensors, wireless communications, and more efficient pumps and controllers. These new developments have...
Complex Regional Pain Syndrome (CRPS) – A Market Briefing
Published: August 1, 2005 | Price: $795.00 – $1,990.00
Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...
Wound Care Markets, 2nd Edition, Vol I – Skin Ulcers
Published: July 1, 2005 | Price: $2,995.00 – $5,990.00
The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in the industry. New product manufacturers can capitalize on these concerns by offering products designed to improve healing rates and prevent wound formation within a cost-conscious framework. Besides the always-improving synthetic...
The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications
Published: July 1, 2005 | Price: $3,000.00 – $6,000.00
This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace. In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of...
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.
Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. This completely updated 2nd edition of Kaloramaās popular 2003 study thoroughly...
The World Market for Anti-Infectives, Volume III – Antivirals
Published: June 1, 2005 | Price: $2,500.00 – $5,000.00
This volume of Kalorama Informationās World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides an An overview Description of products on the market Description of products in development Market estimates and forecasts through 2009 Market segmentation by infection type Market segmentation by geographic region Market share of leading...
The U.S. Market for Home Care Products, 4th Edition
Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
The U.S. market for home care products and equipment continues to post steady gains, primarily as a result of the aging population and increasing shifts of chronic care patients from hospitals to home. In 2004, an estimated 16 million people received home health care in the United States, and most of these individuals also used associated home care products. Through 2009, the numbers of home care patients will continue to grow as patient lifespans are extended with more sophisticated medical...
Minimally Invasive Spinal Surgery – A Market Briefing
Published: June 1, 2005 | Price: $995.00 – $1,990.00
With the promise of improved outcomes and shorter recovery times and costs, endoscopic surgery has evolved into an accepted surgical discipline in most therapeutic areas. However, spine surgeons in particular have been slow to embrace this new technology over the past decade or so. Challenges specific to the spinal column have made the adoption of minimally invasive surgery difficult, but endoscope manufacturers have begun to take advantage of technological advances in endoscopic visualization and other arrears to optimize the minimal-access...
Molecular Imaging Agents and Systems – A Market Briefing
Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...
Synthetic Blood Substitutes and Blood Products – A Market Briefing
Published: June 1, 2005 | Price: $995.00 – $1,990.00
In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been stretched and the dangers of disease transmission have added significant cost pressures to maintaining a safe supply. One possible solution to ease the crunch, particularly in acute amergency care settings...
Hispanics and Healthcare: Understanding Demographics, Health Statistics, and Attitudes for More Effective Marketing
Published: May 1, 2005 | Price: $1,995.00 – $3,990.00
In the last decade the importance of reaching the Hispanic market has become increasingly apparent to marketing practitioners in all industries. Hispanics have not only increased in numbers to become the largest ethnic minority population in the United States, but also increased in purchasing power, representing an estimated $680 billion in 2004 and expected to grow at an average annual rate of 8%. For many industries, including pharmaceutical and healthcare, Hispanics constitute an unfamiliar segment of the market, but one...
Markets in Human Reproductive Medicine
Published: May 1, 2005 | Price: $3,500.00 – $7,000.00
This study provides a comprehensive analysis of available and emerging reproductive products and technologies related to contraception and infertility treatments. The goal of this study is to provide a comprehensive range of information from detailed product analyses through industry trends, and to quantify and qualify the market for hormonal contraceptives, infertility pharmaceuticals, and for assisted reproductive technologies. The report forecasts the following markets through 2008: The world market oral contraceptives The world market hormonal contraceptive devices The world market infertility...
The World Market for Anti-Infectives, Volume II – Antibacterials
Published: May 1, 2005 | Price: $2,500.00 – $5,000.00
For the past 60 years, antibiotic drugs have changed bacterial infections from the life-threatening scourges they once were into eminently treatable conditions. However, the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to traditional agents. As a result, pharmaceutical companies are taking a second look at the antibiotic market, after more than two decades of relative complacency. In addition to the scientific and technical challenges of new antibiotic development, there are significant...
The Worldwide Market for Prescription Cardiovascular Drugs
Published: May 1, 2005 | Price: $3,500.00 – $7,000.00
The worldwide market for prescription cardiovascular drugs encompasses a wide variety of products that treat the many facets of cardiovascular disease. The field of cardiology is currently experiencing a busy and dynamic period. As a result, the range of therapeutic options available to physicians has expanded significantly in the past few years and the development pipeline promises even more weapons soon. The sheer size and diversity of the current market and the potential of new products make this therapeutic category...
Informatics in Drug Discovery: The Evolving Information Technology Marketplace
Published: May 1, 2005 | Price: $3,000.00 – $6,000.00
Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced. In the rapidly changing field of informatics, it is difficult to decode the buzz-words, interpret the extravagant claims, separate true needs from blue-sky wishes. The concerns and strategies of only a year ago...
World Market for Anti-Infectives, Volume I: Antifungals, The
Published: April 1, 2005 | Price: $2,500.00 – $5,000.00
In the past 100 years, there has been a steady increase in the incidence of serious secondary systemic fungal infections. One of the factors aiding the spread of fungal disease has been the widespread use of broad-spectrum antibiotics, which eliminate or decrease the non-pathogenic bacterial populations that normally compete with fungi. Another has been the vast increase in populations with with compromised immune response (caused by AIDS or by the action of immunosuppressant drugs or cancer chemotherapy agents). In addition...
Diabetes and Diabetic Complications: Major World Markets, 2nd Edition
Published: April 1, 2005 | Price: $3,500.00 – $7,000.00
The current market for diabetes products is large and growing. Both monitoring and therapeutic products have an excellent market outlook. Diabetes markets have long had major areas of unmet need, and that has not changed during the past several decades. In fact, the number of diabetic patients, especially in the United States, will increase at an accelerating rate over the next 20 years. With the recognition of diabetes as a public health issue of increasing importance, greater pressure will be...
Schizophrenia Therapeutics: A Market Briefing
Published: April 1, 2005 | Price: $995.00 – $1,990.00
Schizophrenia is a life long affliction. There is no permanent cure for this illness. However, numerous drugs have made the effective management of the disease a reality. This briefing examines both corrent and emerging therapeutic approaches for the management of schizophrenia. It provides an analysis of the current and future markets for these agents, including forecasts to 2009 segmented by geographic region and by type of drug and likely market scenarios for new agents not yet available. The briefing discusses...